FDA Inspection 1277487 — Vitalant Magee Women's Hospital Site
The FDA completed an inspection of Vitalant Magee Women's Hospital Site on July 30, 2025 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 30, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pittsburgh, PA (United States)